SCHEMBL4075839

SCHEMBL4075839

CCNC(=O)NC(=O)CI

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MCL1 Q07820 1/20 0.37
ALDH1A1 P00352 4/20 0.36
FAAH O00519 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9719005 0.80 KMT2A (0.44) NPC1RAB9AMCL1ALDH1A1FAAH
SCHEMBL1655813 0.79
Hydrochloric Acid SCHEMBL181355 0.77
SCHEMBL13285456 0.76 ALDH1A1 (0.39) NPC1RAB9AMCL1ALDH1A1FAAH
SCHEMBL4076701 0.76 SMN1; SMN2 (0.41) NPC1RAB9AMCL1ALDH1A1FAAH
SCHEMBL320068 0.73
SCHEMBL28293734 0.73 MMP1 (0.48) MCL1ALDH1A1FAAHSMN1; SMN2GAA
SCHEMBL28057260 0.72
SCHEMBL19302722 0.72
SCHEMBL25682240 0.71 MCL1 (0.41) NPC1RAB9AMCL1ALDH1A1FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108698424-A Lithographic printing plate precursor for on-press development, method for producing lithographic printing plate, and lithographic printing method 富士胶片株式会社 2018-10-23 CN disclosed
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
EP-1737459-B1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2009-08-05 EP disclosed
EP-1737459-B1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS WARNER LAMBERT CO (US) 2009-08-05 EP disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
EP-1204690-B1 PIGMENT DISPERSANTS FORMED BY REACTING AN ISOCYANATE WITH A POLY(ETHYLENE GLYCOL) ALKYL ETHER, A POLYESTER OR POLYACRYLATE AND A DIAMINE DU PONT (US) 2007-10-03 EP disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed
EP-1737459-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2007-01-03 EP disclosed
WO-2005089763-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-09-29 WO disclosed
EP-1204690-A1 PIGMENT DISPERSANTS FORMED BY REACTING AN ISOCYANATE WITH A POLY(ETHYLENE GLYCOL) ALKYL ETHER, A POLYESTER OR POLYACRYLATE AND A DIAMINE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-05-15 EP disclosed
WO-2001010923-A1 PIGMENT DISPERSANTS FORMED BY REACTING AN ISOCYANATE WITH A POLY(ETHYLENE GLYCOL) ALKYL ETHER, A POLYESTER OR POLYACRYLATE AND A DIAMINE E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL NPC1 575/4885RAB9A 707/4885MCL1 208/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA NPC1 1996/4885RAB9A 1510/4885MCL1 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.